Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colorectal cancer screening

This article was originally published in The Gray Sheet

Executive Summary

Screening guidelines should be modified to include male gender - along with age and family history - as an independent predictor of colorectal cancer "to ensure the maximal diagnostic yield of the screening and the optimal use of resources," according to a study by Jaroslaw Regula, MD, Medical Center for Postgraduate Education, Warsaw, Poland, et al. in the Nov. 2 New England Journal of Medicine. The study, which included more than 50,000 participants ages 40 to 66 in a national colonoscopy screening program in Poland, found that the number of men who would have to undergo screening to detect one advanced neoplasia was significantly lower than the threshold for women in all age groups...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT024152

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel